Global biotechnology leader CSL announced positive top-line Phase 3 results for garadacimab (CSL312), the company's investigational first-in-class monoclonal antibody inhibiting Factor XIIa being developed...
Strata Oncology, Inc., a next-generation precision oncology company enabling smarter and earlier cancer treatment, announced that Sarah Cannon Research Institute (SCRI) has joined the...
Medison Pharma, a global pharma company focused on providing access to highly innovative therapies to patients in international markets, announced the expansion of its...
Orna Therapeutics, a biotechnology company pioneering a new class of fully engineered circular RNA therapies (oRNA), announced the initial closing of its $221 million...
Kronos Bio, Inc., a company dedicated to transforming the lives of those affected by cancer, and Invivoscribe, a global provider of diagnostic kits and...
